Ophthalmic Consultants of Boston (OCB) was founded in 1969 with the primary goal of providing patients with eye care, laser and surgical treatment of the highest quality. In addition to eye examinations, our ophthalmologists provide care in the following specialties: cataract, glaucoma, cornea, diseases of the retina, orbital plastics, pediatrics, LASIK refractive surgery and eye trauma. Our staff of 30 ophthalmologists and 13 optometrists care for over 165,000 patients each year with all categories of eye disorders and visual system diseases. This level of care has earned Ophthalmic Consultan... view company details
Ophthalmology Consultants is a medical practice company based out of United States. view company details
Celebrating Over 30 Years of Engineering Design Excellence: At DuBois Consultants, Inc. (DCI) we are committed to improving the communities in which we serve by providing design solutions tailored to meet our client's visions, while promoting a work environment dedicated to growth and professional development. Founded in 1988, DuBois Consultants Inc. is a CIVIL and STRUCTURAL consulting engineering firm that specializing in the study, design and construction of water facilities and infrastructures with offices in Wichita, Kansas and headquartered in Kansas City, Missouri. Our engineers provide... view company details
Bryant is a geotechnical engineering firm that offers geophysics, remote sensing, numerical modeling and material testing services. view company details
Bernard Personnel is a provider of employee recruitment services for enterprises. view company details
Since 1999, we've been shaping community environments and refining living spaces with one thing in mind'your satisfaction. That's why our three brands, Social Student Spaces, ReNew Apartment Communities and Arrive Luxury Communities, address every stage of life. Because you have your own set of expectations, and our job is to meet every one. We also have resident programs that highlight a level of commitment and care you just don't find every day. Through RENTsparency, SmartHom by Trinity, Green Team and Together, we make sure transparency, customer service, and technology are always front and... view company details
Dicerna is a developer of investigational ribonucleic acid interference therapeutics for liver, cardiovascular and viral infectious diseases. view company details
Glympse Bio is a life science company that develops and manufactures noninvasive sensor products for monitoring cancer and infectious diseases. view company details
Paratek Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics based upon biology and tetracycline chemistry in the United States. Its lead product candidates include omadacycline, an intravenous and oral antibiotic for use as a monotherapy antibiotic for acute bacterial skin and skin structure infections, community-acquired bacterial pneumonia, urinary tract infections, and other community-acquired bacterial infections; and Sarecycline, a tetracycline-derived compound designed for use in the treatment of acne and r... view company details
Dicerna Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery and development of ribonucleic acid interference (RNAi)-based pharmaceuticals. The company develops pharmaceuticals using its GalXC RNAi platform for the treatment of diseases involving the liver, including rare diseases, viral infectious diseases, chronic liver diseases, and cardiovascular diseases. Its principal development programs include DCR-PHXC for the treatment of primary hyperoxaluria; DCR-HBVS for the treatment of chronic hepatitis B virus infection; and a program for an undisclosed rare liver diseas... view company details
GeoVax Labs, Inc., a clinical-stage biotechnology company, develops human vaccines and immunotherapies against infectious diseases and cancers using modified vaccinia ankara virus-like particle vaccine platform in the United States and internationally. It is developing various preventive vaccines against human immunodeficiency virus (HIV); Zika virus; malaria; and hemorrhagic fever viruses, such as Ebola, Sudan, Marburg, and Lassa, as well as therapeutic vaccines for chronic Hepatitis B infections and cancers. The company has collaboration and partnership agreements with the National Institute... view company details
Cidara Therapeutics, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of novel anti-infectives for the treatment of diseases in the United States. Its lead product candidate is rezafungin acetate, a novel molecule in the echinocandin class of antifungals for the treatment and prevention of serious invasive fungal infections, including candidemia and invasive candidiasis, which are fungal infections associated with high mortality rates. The company, through its Cloudbreak platform, focuses on the treatment of infectious diseases that include viral and ... view company details